Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 38347-38348 [2013-15193]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 123 / Wednesday, June 26, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:00 a.m.–2:30 p.m., July
18, 2013.
Place: Shilo Inn, 780 Lindsay Blvd., Idaho
Falls, Idaho 83402; Phone: 208–523–0088;
Fax: 208–522–7420.
Status: Open to the public, but without a
public comment period. To access by
conference call dial the following
information 1(866)659–0537, Participant Pass
Code 9933701.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act of 2000 to
advise the President on a variety of policy
and technical functions required to
implement and effectively manage the
compensation program. Key functions of the
ABRWH include providing advice on the
development of probability of causation
guidelines that have been promulgated by the
Department of Health and Human Services
(HHS) as a final rule; advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the ABRWH to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2013.
Purpose: The ABRWH is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS, advising
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is a
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class. The Subcommittee on
Procedures Review was established to aid the
ABRWH in carrying out its duty to advise the
Secretary, HHS, on dose reconstructions. The
Subcommittee on Procedures Review is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes
discussion of the following ORAU and DCAS
procedures: OTIB–054 (‘‘Fission and
Activation Product Assignment for Internal
Dose-Related Gross Beta and Gross Gamma
VerDate Mar<15>2010
20:26 Jun 25, 2013
Jkt 229001
Analyses’’), OTIB–0055 (‘‘Conversion from
NCRP Report 38 Neutron Quality Factors to
ICRP Pub. 60’’), Program Evaluation Report
(PER) 011 (‘‘K–25 TBD and TIB Revisions’’),
PER 014 (‘‘Construction Trades Workers’’),
PER 020 (‘‘Blockson Technical Basis
Document’’), PER 25 (‘‘Huntington Pilot Plant
TBD Revision’’), PER 031 (‘‘Y–12 TBD
Revisions’’), PER 033 (‘‘Reduction Pilot Plant
TBD Revision’’), PER 037 (‘‘Ames TBD
Revision’’), PER 038 (‘‘Hooker
Electrochemical TBD Revision’’), ORAUT–
PROC–0044 (‘‘Special Exposure Cohort’’);
ORAUT Report 0053 (‘‘Stratified Co-Worker
Sets); and a continuation of the commentresolution process for other dose
reconstruction procedures under review by
the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public, but
without a public comment period. In the
event an individual wishes to provide
comments, written comments may be
submitted. Any written comments received
will be provided at the meeting and should
be submitted to the contact person below in
advance of the meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal Official,
NIOSH, CDC, 1600 Clifton Road, Mailstop
E–20, Atlanta GA 30333, Telephone
(513)533–6800, Toll Free 1(800)CDC–INFO,
Email dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–15194 Filed 6–25–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates (All
times are Mountain Time): 8:15 a.m.–5:00
p.m., July 16, 2013. 8:15 a.m.–5:30 p.m., July
17, 2013.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
38347
Public Comment Times and Dates (All
times are Mountain Time): 5:00 p.m.–6:00
p.m.*, July 16, 2013.
*Please note that the public comment periods
may end before the times indicated,
following the last call for comments.
Members of the public who wish to provide
public comments should plan to attend
public comment sessions at the start times
listed.
Place: Shilo Inn, 780 Lindsay Blvd., Idaho
Falls, Idaho 83402; Phone: 208–523–0088;
Fax: 208–522–7420. Audio Conference Call
via FTS Conferencing. The USA toll-free,
dial-in number is 1–866–659–0537 with a
pass code of 9933701. Live Meeting
Connection: https://www.livemeeting.com/
cc/cdc/join?id=MZS2ZW&role=attend&
pw=ABRWH; Meeting ID: MZS2ZW; Entry
Code: ABRWH
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2013.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the Advisory Board meeting includes: NIOSH
Program Update; Department of Labor
Program Update; Department of Energy
Program Update; SEC petitions for: Rocky
Flats Plant, Baker Brothers (Toledo, OH;
1945–1996), Pantex Plant (1951–1957, 1984–
E:\FR\FM\26JNN1.SGM
26JNN1
mstockstill on DSK4VPTVN1PROD with NOTICES
38348
Federal Register / Vol. 78, No. 123 / Wednesday, June 26, 2013 / Notices
1991), Feeds Materials Production Center
(Fernald, Ohio); Site Profile reviews for:
General Steel Industries, Brookhaven
National Laboratory; Procedures Review
Subcommittee Report; SEC Issues Work
Group Report on ‘‘Sufficient Accuracy’’;
Discussion of Co-Worker Dose Modeling;
Idaho National Laboratory Site Profile
Revisions Update; SEC Petitions Update, and
Board Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as outlined
in (a) above will also appear with the agenda
for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in
(a) above will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an individual
in making a statement reveals personal
information (e.g., medical information) about
themselves that information will not usually
be redacted. The NIOSH FOIA coordinator
will, however, review such revelations in
accordance with the Freedom of Information
Act and the Federal Advisory Committee Act
and if deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Theodore Katz, Designated Federal Official,
NIOSH, CDC, 1600 Clifton Road, MS E–20,
Atlanta GA 30333, telephone: (513)533–6800,
toll free: 1–800–CDC–INFO, email:
dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Mar<15>2010
20:26 Jun 25, 2013
Jkt 229001
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–15193 Filed 6–25–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0730]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Threshold of
Regulation for Substances Used in
Food-Contact Articles
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
requests for exemption from the
Threshold of Regulation for Substances
Used in Food-Contact Articles.
DATES: Submit either electronic or
written comments on the collection of
information by August 26, 2013.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850,
domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, we are publishing notice of
the proposed collection of information
set forth in this document.
With respect to the following
collection of information, we invite
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Threshold of Regulation for Substances
Used in Food-Contact Articles—21 CFR
170.39 (OMB Control Number 0910–
0298)—Extension
Under section 409(a) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 348(a)), the use of
a food additive is deemed unsafe unless
one of the following is applicable: (1) It
conforms to an exemption for
investigational use under section 409(j)
of the FD&C Act; (2) it conforms to the
terms of a regulation prescribing its use;
or (3) in the case of a food additive
which meets the definition of a foodcontact substance in section 409(h)(6) of
the FD&C Act, there is either a
regulation authorizing its use in
accordance with section 409(a)(3)(A) or
an effective notification in accordance
with section 409(a)(3)(B).
The regulations in § 170.39 (21 CFR
170.39) established a process that
provides the manufacturer with an
opportunity to demonstrate that the
likelihood or extent of migration to food
of a substance used in a food-contact
article is so trivial that the use need not
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 78, Number 123 (Wednesday, June 26, 2013)]
[Notices]
[Pages 38347-38348]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-15193]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Mountain
Time): 8:15 a.m.-5:00 p.m., July 16, 2013. 8:15 a.m.-5:30 p.m., July
17, 2013.
Public Comment Times and Dates (All times are Mountain Time):
5:00 p.m.-6:00 p.m.*, July 16, 2013.
*Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of
the public who wish to provide public comments should plan to attend
public comment sessions at the start times listed.
Place: Shilo Inn, 780 Lindsay Blvd., Idaho Falls, Idaho 83402;
Phone: 208-523-0088; Fax: 208-522-7420. Audio Conference Call via
FTS Conferencing. The USA toll-free, dial-in number is 1-866-659-
0537 with a pass code of 9933701. Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=MZS2ZW&role=attend&pw=ABRWH pw=ABRWH;
Meeting ID: MZS2ZW; Entry Code: ABRWH
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
which have been promulgated by the Department of Health and Human
Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2013.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters To Be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC petitions for:
Rocky Flats Plant, Baker Brothers (Toledo, OH; 1945-1996), Pantex
Plant (1951-1957, 1984-
[[Page 38348]]
1991), Feeds Materials Production Center (Fernald, Ohio); Site
Profile reviews for: General Steel Industries, Brookhaven National
Laboratory; Procedures Review Subcommittee Report; SEC Issues Work
Group Report on ``Sufficient Accuracy''; Discussion of Co-Worker
Dose Modeling; Idaho National Laboratory Site Profile Revisions
Update; SEC Petitions Update, and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment): (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Theodore Katz, Designated
Federal Official, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta GA
30333, telephone: (513)533-6800, toll free: 1-800-CDC-INFO, email:
dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-15193 Filed 6-25-13; 8:45 am]
BILLING CODE 4163-18-P
